SUNCT responding to botulinum toxin (P3.049)

Conclusions: OnabotulinumtoxinA injection is a therapeutic option for refractory cases of SUNCT.Disclosure: Dr. Wijemanne has nothing to disclose. Dr. Jankovic has received personal compensation for activities with Adamas Pharmaecuticals, Inc, Allergan, Inc, Auspex Pharmaceuticals, Inc, Lundbeck Inc, and Teva Pharmaceutical Industries Ltd. Dr. Jankovic has received personal compensation in an editor

Source: Neurology - April 8, 2015 Category: Neurology Authors: Wijemanne, S., Jankovic, J. Tags: Headache II Source Type: research